Alliance A021804: A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide versus Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma
- Citation:
- J Clin Oncol vol 41 (suppl 16) TPS4191
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Jaydira del Rivero Kimberly J. Perez Susan Geyer Maged Khalil Aishwarya Vijendrn Andrea Kordaris-Corkill Ardaman Shergill Kristen Spencer Heloisa Soares Charles Lopez Andre Nixon Amylou Dueck Jeffrey Meyerhardt Eileen M. O'Reill
- Networks:
- LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-UT003, MCRC, MD001, OR013
- Study
- Alliance-A021804
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: